Membrane activity of biotechnological peptide drugs.

A. Malkia,P. Liljeroth,K. Kontturi
DOI: https://doi.org/10.1039/B300816A
IF: 4.9
2003-11-17
Chemical Communications
Abstract:Charged Langmuir-Blodgett monolayers deposited at an immobilised liquid-liquid interface have been used as a simple model for a biological membrane to investigate the membrane activity of biotechnological oligopeptide drugs.
What problem does this paper attempt to address?